| NDC Code | 83027-0150-1 |
|---|
| Package Description | 60 mL in 1 BOTTLE, SPRAY (83027-0150-1) |
|---|
| Product NDC | 83027-0150 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Viri Sode |
|---|
| Non-Proprietary Name | Cytomegalovirus Nosode, Herpes Simplex I Nosode, Herpes Simplex Ii Nosode, Influenzinum (2024-2025), Rubella Nosode, Hepatitis A Nosode, Hepatitis B Nosode, Hepatitis C Nosode, Epstein Barr Virus Nosode, Herpes Zoster Nosode |
|---|
| Dosage Form | SPRAY |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20250603 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Nutritional Specialties, Inc. |
|---|
| Substance Name | HEPATITIS A VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; INFLUENZA A VIRUS A/THAILAND/8/2022 IVR-237 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; RUBELLA VIRUS |
|---|
| Strength | 30; 30; 30; 16; 16; 15; 15; 16; 15; 15; 15; 15; 16 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL |
|---|